Logo image
First report of amecA-positive multidrug-resistant Staphylococcus pseudintermedius isolated from a dog in New Zealand
Journal article   Open access   Peer reviewed

First report of amecA-positive multidrug-resistant Staphylococcus pseudintermedius isolated from a dog in New Zealand

A.G. Bell, G.W. Coombs, B. Cater and C. Douglass
New Zealand Veterinary Journal, Vol.64(4), pp.253-256
2016
pdf
mecA-positive-multidrug-resistant-Staphylococcus-pseudintermedius.pdfDownloadView
Author’s Version Open Access
url
Link to Published Version *Subscription may be requiredView

Abstract

CASE HISTORY A 14-year-old neutered male Sealyham terrier was referred for assessment of a persistent pyoderma. It had experienced numerous episodes of dermatitis involving pododermatitis, pyoderma and otitis over the previous 6 years. CLINICAL FINDINGS Superficial, focally deep and mucocutaneous pyoderma were present, with yellow mucoid exudate on both nares and the lower lips crusted with haemopurulent exudate. Epidermal collarettes were present on the dorsal and lateral trunk. There were peri-anal crusts and mild erythema was present on the concave aspect of both pinnae. MICROBIOLOGICAL FINDINGS Culture and microbiological testing identified Staphylococcus pseudintermedius as the infecting organism. Kirby-Bauer disc susceptibility testing revealed the isolate was resistant to numerous antimicrobials including oxacillin. PCR testing of the isolate identified the presence of the mecA gene which confers resistance to β-lactam antimicrobials. Pulsed field gel electrophoresis typing suggested the isolate was not related to the methicillin-resistant S. pseudintermedius that had been reported to be associated with canine infections in Western Australia. DIAGNOSIS Superficial, deep and mucus membrane pyoderma associated with a multi-drug resistant S. pseudintermedius. CLINICAL RELEVANCE This is the first recorded case of canine pyoderma involving methicillin-resistant multidrug-resistant S. pseudintermedius in New Zealand. Treatment of such cases is difficult because the number of effective and available antimicrobials is limited. This finding should raise the awareness of the veterinary and medical professions to the presence of such organisms in New Zealand and stimulate a discussion about possible biosecurity barriers, treatment strategies and prevention of zoonotic and nosocomial infections.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

281 File views/ downloads
102 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
International collaboration
Citation topics
1 Clinical & Life Sciences
1.23 Antibiotics & Antimicrobials
1.23.173 MRSA and VRE
Web Of Science research areas
Veterinary Sciences
ESI research areas
Plant & Animal Science
Logo image